Erik L. Ridley and Philip Ward[email protected]AIRadNet broadens AI focus with acquisitions of Aidence, QuantibImaging services provider RadNet has acquired Dutch artificial intelligence (AI) software developers Aidence and Quantib in deals that the company hopes will enable wide-scale screening programs for lung and prostate cancer.January 23, 2022Page 1 of 1Top StoriesASTRO 2026ASTRO: Proton RT controls high-risk neuroblastomaFindings support PRT as a strategy to reduce long-term morbidity without compromising oncologic outcomes.ASTRO 2026ASTRO: How does tumor location affect survival in patients with esophageal cancer?CTCT-based AI model predicts pneumonitis in lung cancer patientsWomens ImagingWomen's Imaging MinnieCast, Episode 18: On the road with the LBCASponsor ContentFree webinar for radiology leaders